Earnings Feed
Start Free
Home/Filings/4/0001662579-23-000008
4//SEC Filing

Anderson Kenneth Carl 4

Accession 0001662579-23-000008

CIK 0001662579other
View on SEC.govCompany Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:55 PM ET

Size

14.9 KB

Accession

0001662579-23-000008

Insider Transaction Report

Form 4
Period: 2023-01-06
C4 Therapeutics, Inc.CCCC
Anderson Kenneth Carl
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-06$2.11/sh+268$565→ 94,684 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-06−268→ 1,067 total
    Exercise: $2.11Exp: 2026-07-12→ Common Stock (268 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-06−444→ 890 total
    Exercise: $4.98Exp: 2030-07-02→ Common Stock (444 underlying)
  • Exercise/Conversion

    Common Stock

    2023-01-06$4.98/sh+444$2,211→ 95,128 total
Holdings

  • Common Stock

    (indirect: By Spouse)
    47,316

  • Common Stock

    (indirect: By Trust)
    61,265

  • Common Stock

    (indirect: By Trust)
    61,265

  • Common Stock

    (indirect: By Trust)
    16,939

  • Common Stock

    (indirect: By Trust)
    16,939
Footnotes (6)
  • [F1]Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F2]Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F3]Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F4]Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F5]12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter.
  • [F6]The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020.

Documents

1 file

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

→
Entity typeother

Related Parties

1
  • filerCIK 0001824862

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:55 PM ET
Size
14.9 KB
View on SEC.gov